de Verneuil Vanina (CIK 2036234) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-26). Recent activity: Sell VIR (3,117 shares), Sell VIR (13,700 shares), Buy VIR (55,000 shares), Sell VIR (4,445 shares), Sell VIR (2,385 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-26 | Vir Biotechnology, Inc. (VIR) | EVP, General Counsel, Corp Sec | Sell | 3,117 | $29,705 |
| 2026-02-26 | Vir Biotechnology, Inc. (VIR) | EVP, General Counsel, Corp Sec | Sell | 13,700 | $134,534 |
| 2026-02-24 | Vir Biotechnology, Inc. (VIR) | EVP, General Counsel, Corp Sec | Buy | 55,000 | $0 |
| 2026-02-24 | Vir Biotechnology, Inc. (VIR) | EVP, General Counsel, Corp Sec | Sell | 4,445 | $33,115 |
| 2025-11-07 | Vir Biotechnology, Inc. (VIR) | EVP, General Counsel, Corp Sec | Sell | 2,385 | $12,307 |
| 2025-11-04 | Vir Biotechnology, Inc. (VIR) | EVP and General Counsel | Sell | 1,365 | $7,999 |
| 2025-02-27 | Vir Biotechnology, Inc. (VIR) | EVP and General Counsel | Sell | 7,373 | $67,389 |
| 2025-02-25 | Vir Biotechnology, Inc. (VIR) | EVP and General Counsel | Buy | 35,000 | $0 |
| 2025-02-25 | Vir Biotechnology, Inc. (VIR) | EVP and General Counsel | Sell | 5,140 | $48,573 |
Source: SEC Form 4 filings · as of 2026-02-26